MORPHEE : Mechanisms of Cell Death Induced by Extracorporeal Photochemotherapy

Recruiting N/A Interventional Study
Cutaneous T-Cell Lymphoma Graft Vs Host Disease Graft Rejection
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 85
Sex
Any
Study type
Interventional
Purpose
Basic Science
Participants needed
20 (estimated)
Sponsor
Centre Hospitalier Universitaire de Besancon · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The objective of this study is to describe the type of cell death induced by extracorporeal photochemotherapy, depending on the cell type, using a panel of complementary analysis techniques.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Adult patients * Treated with ECP for at least 1 month, for control of GVHD in hematopoietic cell allograft (acute or chronic GVHD), treatment and control of cellular or humoral rejection in solid organ transplantation (heart, lung, kidney) or in the treatment of cutaneous T-c…
Contacts

Charline VAUCHY, PhD

+33381218875

cvauchy@chu-besancon.fr

CONTACT